Status | Study |
RECRUITING |
Study Name: A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms. Condition: Lupus Erythematosus, Systemic Date: 2023-05-18 Interventions: Placebo (intravenous infusion) |
RECRUITING |
Study Name: A Study of CC-97540 in Participants With Severe, Refractory Systemic Lupus Erythematosus (SLE) Condition: Lupus Erythematosus, Systemic Date: 2023-05-11 Interventions: Specified dose on specified days |
RECRUITING |
Study Name: Relationship Between Data Obtained With the LuGENE� Multiparameter Transcriptomics Blood Test and Clinical and Standard Laboratory Features of Patients With SLE (ReLATE) Condition: Lupus Erythematosus, Systemic Date: 2023-04-04 Interventions: LuGENE�, a transcriptomic-based LDT, with standard evaluation of patients diagnosed with SLE |
RECRUITING |
Study Name: Efficacy and Safety of Telitacicept in Early SLE Condition: Date: 2023-03-26 Interventions: 160mg once a week for 48 weeks |
RECRUITING |
Study Name: A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus Condition: Lupus Erythematosus, Systemic Date: 2023-01-03 Interventions: Cenerimod will be supplied as film-coated tablets at the dose of 4 mg. |
RECRUITING |
Study Name: Engagement in CHildhood-Onset Systemic Lupus Condition: Lupus Erythematosus, Systemic Date: 2022-12-05 Interventions: Valera mobile health application will provide educational materials around mental health and Systemic Lupus Erythematosus (SLE) and the ability to con |
Not yet recruiting |
Study Name: A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus Condition: Lupus Erythematosus, Systemic Date: 2017-05-18 Interventions: Drug: CC-220 0.45 mg QD PO |
Recruiting |
Study Name: A Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in Subjects With Active Systemic Lupus Erythematosus (SLE) Condition: Lupus Erythematosus, Systemic Date: 2016-11-01 Interventions: Drug: Repository corticotropin injection |
Not yet recruiting |
Study Name: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-56022473 in Subjects With Systemic Lupus Erythematosus Condition: Lupus Erythematosus, Systemic Date: 2016-09-29 Interventions: Drug: JNJ-56022473 Subjects wi |
Not yet recruiting |
Study Name: Effect of Qi Gong Training on Quality of Life in Patients With Systemic Lupus Erythematous (LuQi) Condition: Lupus Erythematosus, Systemic Date: 2016-03-29 Interventions: Other: Qi Gong The aim of this study is to evaluate the effects of Qi Gong on quality if life in patient |